| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/18/2009 | WO2003060153A3 Irak-m is a negative regulator of toll-like receptor signaling |
| 06/18/2009 | WO2002079494A3 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 06/18/2009 | US20090158470 Compositions and methods for the treatment of Pierce's Disease |
| 06/18/2009 | US20090158468 Metabolic engineering of lipid metabolism by improving fatty acid binding and transport |
| 06/18/2009 | US20090158467 Methods and compositions for modulating flowering and maturity in plants |
| 06/18/2009 | US20090158466 Plants having increased tolerance to heat stress |
| 06/18/2009 | US20090158464 Soybean promoter ltp4 and flower-preferred expression thereof in transgenic plants |
| 06/18/2009 | US20090158461 Transcription Factor Stress-Related Proteins and Methods of Use in Plants |
| 06/18/2009 | US20090158460 Plant Diacylglycerol Acyltransferases |
| 06/18/2009 | US20090158458 Drought tolerant plants and related constructs and methods involving genes encoding ferrochelatases |
| 06/18/2009 | US20090158457 Specific expression using transcriptional control sequences in plants |
| 06/18/2009 | US20090158456 Polynucleotides Encoding Phenylpropanoid Pathway Enzymes in Coffee |
| 06/18/2009 | US20090158455 Compositions and methods for modulating lysine production |
| 06/18/2009 | US20090158454 Lecitin-like protein kinase stress-related polypeptides and methods of use in plants |
| 06/18/2009 | US20090158453 Soybean cultivar sg3870nrr |
| 06/18/2009 | US20090158452 Transgenic plants with enhanced agronomic traits |
| 06/18/2009 | US20090158448 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity |
| 06/18/2009 | US20090156890 Peroxisome proliferator-activator receptor delta (ppardelta) and the development of preimplantation embryos |
| 06/18/2009 | US20090156794 Compositions and methods for activating genes of interest |
| 06/18/2009 | US20090156790 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 06/18/2009 | US20090156668 Ginkgolide Compounds, Compositions, And Extracts, And Uses Thereof |
| 06/18/2009 | US20090156633 Heterocyclic quinolone derivatives that inhbit prolyl hydroxylase activity |
| 06/18/2009 | US20090156622 2,4-pyrimidinediamine compounds and their uses |
| 06/18/2009 | US20090156620 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto |
| 06/18/2009 | US20090156605 Quinolones and azaquinolones that inhbit prolyl hydroxylase |
| 06/18/2009 | US20090156530 Norepinepherine Transporter Mutants and Uses Thereof |
| 06/18/2009 | US20090156526 Compositions and methods for modulation of lmna expression |
| 06/18/2009 | US20090156520 Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA |
| 06/18/2009 | US20090156510 Use of notch signaling regulators for modulating osteogenesis |
| 06/18/2009 | US20090156503 Cell penetrating peptides for intracellular delivery of molecules |
| 06/18/2009 | US20090156497 Non-cytotoxic PAP mutants |
| 06/18/2009 | US20090156489 Promotion of axonal regeneration |
| 06/18/2009 | US20090156479 Methods and Means for Controlling the Endocytosis and Subsequent Degradation of a Cell Surface Protein |
| 06/18/2009 | US20090156470 Interfering rna delivery system and uses thereof |
| 06/18/2009 | US20090156469 Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating waldenstrom's macroglobulinemia |
| 06/18/2009 | US20090156467 Thymic stromal lymphpoietin promoter and use therefor |
| 06/18/2009 | US20090156458 Assay for the detection of factors that modulate the expression of inagp |
| 06/18/2009 | US20090156457 Methods and means for screening for rhomboid activity |
| 06/18/2009 | US20090155912 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 06/18/2009 | US20090155911 Genetically modified plants and their applications in phytoremediation |
| 06/18/2009 | US20090155910 Down-regulation of gene expression using artificial micrornas |
| 06/18/2009 | US20090155909 Down-regulation of gene expression using artificial micrornas |
| 06/18/2009 | US20090155908 Bioreactor for cell growth and associated methods |
| 06/18/2009 | US20090155907 Removal of Embedding Medium |
| 06/18/2009 | US20090155906 Cell differentiation suppressing agent, method of culturing cells using the same, culture solution, and cultured cell line |
| 06/18/2009 | US20090155905 Composition and Method for Increasing Apoptosis in Cancer Cells |
| 06/18/2009 | US20090155904 Method of inhibiting expression of target mrna using sirna consisting of nucleotide sequence complementary to said target mrna |
| 06/18/2009 | US20090155903 Pharmaceutical composition and method |
| 06/18/2009 | US20090155902 Manipulation of Cells on a Droplet Actuator |
| 06/18/2009 | US20090155901 Mammalian Cell Line Expressing Inducible c-Src |
| 06/18/2009 | US20090155900 Cell culture matrices |
| 06/18/2009 | US20090155899 Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties |
| 06/18/2009 | US20090155898 Method for producing dendritic cells |
| 06/18/2009 | US20090155897 Glycoprotein vi fusion proteins |
| 06/18/2009 | US20090155896 Human Cancer Suppressor Gene, Protein Encoded Therein, Expression Vector Containing The Same, And Cell Transformed By The Vector |
| 06/18/2009 | US20090155878 Apparatus, method and system for creating, handling, collecting and indexing seed and seed portions from plant seed |
| 06/18/2009 | US20090155846 Kinase anchor protein muteins, peptides thereof and related methods |
| 06/18/2009 | US20090155845 Molecules designated LDCAM |
| 06/18/2009 | US20090155844 METHOD OF SYNTHESIZING A SUPPRESSOR tRNA, DNA CONSTRUCT AND USE THEREOF FOR PRODUCING A NON-NATURAL AMINO ACID-INCORPORATED PROTEIN |
| 06/18/2009 | US20090155843 Tnf antagonists |
| 06/18/2009 | US20090155836 Methods for treating hiv infected subjects |
| 06/18/2009 | US20090155831 Cardiomyocytes and methods of producing and purifying cardiomyocytes |
| 06/18/2009 | US20090155806 identifying biallelic markers of a FLAP gene and the association established between these markers and diseases involving the leukotriene pathway such as asthma |
| 06/18/2009 | US20090155802 Mutant DNA Polymerases with Improved Pyrophasphorolysis Activated Polymerization (PAP) Ability |
| 06/18/2009 | US20090155797 Methods For Generating Enhanced Antibody-Producing Cell Lines With Improved Growth Characteristics |
| 06/18/2009 | US20090155789 Genes from the 20q13 amplicon and their uses |
| 06/18/2009 | US20090155763 Compositions and methods for prolonging survival of platelets |
| 06/18/2009 | US20090155413 Enzyme |
| 06/18/2009 | US20090155376 Protein hydrolysate with antidiabetic effect |
| 06/18/2009 | US20090155350 Chlamydia antigens and protein vaccine |
| 06/18/2009 | US20090155349 Methods of treating influenza viral infections |
| 06/18/2009 | US20090155340 Method of cell storage in a delivery system |
| 06/18/2009 | US20090155333 Dermis-Derived Cells for Tissue Engineering Applications |
| 06/18/2009 | US20090155301 Pseudoinfectious flavivirus and uses thereof |
| 06/18/2009 | US20090155299 Antibodies for the Detection of Bacillus Anthracis and Vaccine Against B. Anthracis Infections |
| 06/18/2009 | US20090155298 Matrix Metalloproteinase 11 Vaccine |
| 06/18/2009 | US20090155283 Noncompetitive Domain Antibody Formats That Bind Interleukin 1 Receptor Type 1 |
| 06/18/2009 | US20090155282 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 06/18/2009 | US20090155279 Pseudomonas Aeruginosa Outer Membrane Protein PA5158 |
| 06/18/2009 | US20090155278 Claudins as Markers for Early Detection, Diagnosis, Prognosis and as Targets of Therapy for Breast and Metastatic Brain or Bone Cancer |
| 06/18/2009 | US20090155271 pro-inflammatory cytokines, interleukins (IL-17A, IL-17F) |
| 06/18/2009 | US20090155270 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza |
| 06/18/2009 | US20090155269 Mesothelin antibody protein fusions and methods of use |
| 06/18/2009 | US20090155268 Growth Factor Binding Constructs Materials and Methods |
| 06/18/2009 | US20090155262 Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 06/18/2009 | US20090155257 Immunoglobulin variants and uses thereof |
| 06/18/2009 | US20090155255 Cd23 binding molecules and methods of use thereof |
| 06/18/2009 | US20090155251 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 06/18/2009 | US20090155250 Monoclonal antibodies against orthopoxviruses |
| 06/18/2009 | US20090155249 Humanized antibody igg1 |
| 06/18/2009 | US20090155247 Methods of Using Death Receptor Agonists and EGFR Inhibitors |
| 06/18/2009 | US20090155242 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response |
| 06/18/2009 | US20090155238 Xylanases, nucleic acids encoding them and methods for making and using them |
| 06/18/2009 | US20090155232 Neonatal human hepatocytes immortalized using tert and methods of their use |
| 06/18/2009 | US20090155231 delivering a therapeutic agent to a solid tumor characterized by hypoxia, acidosis and hypertonicity comprising loading the therapeutic agent into sickle red blood cells; tissue targeted therapy; drug delivery |
| 06/18/2009 | US20090155228 Compounds, kits and methods for conferring cytoprotection |
| 06/18/2009 | US20090155226 Regenerative Dot cells |
| 06/18/2009 | US20090155225 Uses and isolation of very small of embryonic-like (vsel) stem cells |
| 06/18/2009 | US20090155223 Cell-based compositions and methods for treating conditions of the nervous system |
| 06/18/2009 | US20090155222 Cell culture |